Editorial: What Ails Solid Tumor Radioimmunotherapy?
- 1 April 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 21 (2), 81-84
- https://doi.org/10.1089/cbr.2006.21.81
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Editorial: Radioimmunotherapy, a New Breakthrough in the Treatment of Follicular Non-Hodgkin's Lymphoma: The European PerspectiveCancer Biotherapy & Radiopharmaceuticals, 2006
- Treatment Strategies in Follicular Lymphomas: Current Status and Future PerspectivesJournal of Clinical Oncology, 2005
- Monoclonal antibody therapy of cancerNature Biotechnology, 2005
- Pharmacogenetics in Cancer ChemotherapyTherapeutic Drug Monitoring, 2004
- Cancer cells compress intratumour vesselsNature, 2004
- A Novel Monoclonal Antibody Design for RadioimmunotherapyCancer Biotherapy & Radiopharmaceuticals, 2003
- Hematologic Toxicity in Radioimmunotherapy: Dose-Response Relationships for I-131 Labeled Antibody TherapyCancer Biotherapy & Radiopharmaceuticals, 2002
- In vivo diagnosis and therapy of human tumors with monoclonal antibodies: Selection of antibodies and preliminary clinical studies in small cell carcinoma of the lungInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1989
- Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with CarcinomaNew England Journal of Medicine, 1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978